Controversial ALS Drug Gets Thumbs Up From FDA Advisors

(MedPage Today) -- In an unexpected reversal, an FDA advisory committee voted 7-2 on Wednesday to support approval of AMX0035, an investigational drug being evaluated for amyotrophic lateral sclerosis (ALS). In late March, the same panel voted...
Source: MedPage Today Public Health - Category: American Health Source Type: news